Connect with us

Government

Futures On Edge As Quad-Watching Set To Wipe Out A Third Of Market Gamma

Futures On Edge As Quad-Watching Set To Wipe Out A Third Of Market Gamma

Quad-witching opex Friday has arrived, bringing with it the usual drama of gigantic gamma expiration, including $1.5trillion of SPX index,
$310bln of options on ES futs,

Published

on

Futures On Edge As Quad-Watching Set To Wipe Out A Third Of Market Gamma

Quad-witching opex Friday has arrived, bringing with it the usual drama of gigantic gamma expiration, including $1.5trillion of SPX index,
$310bln of options on ES futs, $220bln of SPY options, $610bln of other index...

... a surge in market volumes, spike in volatility and now expected rebound in risk assetsWith over a third of market gamma set to expire today - specifically some 35% of SPX, 50% SPY, and 35% of QQQ gamma according to SpotGamma - brace for a bump ride as the absolutely gargantuan S&P pin at 4,500 is about to get much smaller, drastically reducing the market's downside buffer.

What does this mean for markets so far? Well, overnight, stock-index futures dropped again, while European stocks erased gains as investors not only fretted about today's quad-witch volatility, but as steady Treasury yields after strong economic data this week pointed toward more movement out of heavyweight technology stocks while next week's FOMC meeting raised concerns about the coming taper and reduction in stimulus. Quantifying that, S&P 500 E-minis were down 11 points, or 0.25%, at 07:30 am ET; Dow E-minis were down 78 points, or 0.22%, while Nasdaq 100 E-minis were down 40 points, or 0.25%. 10-year TSY yields were slightly higher at 1.3429%, while the dollar was unchanged and cryptos dropped.

In overnight trading, FAANG stocks fell slightly in premarket trading. Losses in major tech stocks had pulled the S&P 500 lower on Thursday, after a jump in bond yields saw investors pivot into sectors most likely to benefit from an economic recovery this year. The retail sales reading came on the heels of data showing steady factory activity and a cooling in inflation, which suggested the U.S. economic recovery was resilient despite a recent rise in cases of the Delta COVID-19 variant. Here are some of the biggest movers today:

  • IronNet (IRNT US) drops 9.4% in U.S. premarket trading, paring some of its 114% rally over the past three sessions driven by retail traders; Other meme stock moves: Offerpad (OPAD US) also sinks after doubling this week, while SmileDirectClub (SDC US) rose 7.5%
  • AbCellera Biologics (ABCL US) soars 16% in premarket trading after it confirmed that the U.S. FDA expanded its emergency authorization to use a Lilly-partnered Covid-19 antibody cocktail for post-exposure prevention of infection or symptomatic disease
  • U.S. Steel (X US) dips 1.7% in premarket trading after reporting results on Thursday evening; European steel stocks traded a tad weaker alongside mining stocks, which were hurt sinking iron prices
  • Las Vegas Sands (LVS US) and Wynn Resorts (WYNN US), battered by a shift in policy in Macau, in focus after Jefferies puts out a bearish note. It cut Las Vegas Sands to hold and slashed Wynn’s PT to Street low.
  • Take-Two Interactive Software (TTWO US) slides 1.7% in premarket after it got downgraded to market perform from outperform at BMO on reduced confidence in previously Street- high earnings estimates
  • Tuesday Morning (TUEM US) rises 3.6% in premarket trading after CEO discloses share purchases on Thursday
  • Diamondback Energy (FANG US) climbs 3.7% in premarket trading after it announced a share buyback plan late on Friday
  • Shares gain about 1.8% postmarket
  • Usana Health (USNA US) fell 2.8% in postmarket trading Thursday after cutting its net sales forecast for the full year

Also overnight, China boosted its injection of short-term cash into the financial system in a sign the authorities are seeking to soothe market nerves frayed by concern over quarter-end funding needs and China Evergrande Group’s debt crisis. Still, price swings are almost certain to surge during today's quadruple-witching session, in which a significant number of futures contracts and options expire at the same time, according to Pierre Veyret, technical analyst at ActivTrades. “Most market operators are looking towards the next Fed policy meeting due next week, which should decrease market directionality and increase volatility further,” Veyret said.

Focus now turns to a meeting of the Federal Reserve next week, with investors debating if a swathe of strong economic data this week could spur the bank into shortening its timeline for reducing monetary stimulus.

European shares faded early gains and the Stoxx 600 index traded down -0.1%, erasing a gain of as much as 0.8% as a rally in travel and retail shares was offset by a retreat for basic-resources companies after comments by a European Central Bank council member stoked inflation concerns. ECB Governing Council member Martins Kazaks said the euro area’s inflation outlook may turn out higher than currently anticipated if the coronavirus doesn’t inflict any further shocks. The region’s stabilizing economic recovery, persistent supply bottlenecks and rising expectations all point to possible faster-than-forecast price gains, he said. Maybe he finally got his electric bill?

Commerzbank gained as much as 4.9% after a report that Cerberus Capital would consider raising its stake if the German government was ready to sell its shares. Azelis SA, a distributor of food additives and specialty chemicals, surged in its Brussels trading debut after the biggest Belgian initial public offering since 2007. Anglo American fell 4.2% in London after the miner was downgraded at Morgan Stanley and UBS. European steel stocks traded a tad weaker alongside mining stocks, which were hurt sinking iron prices.

“Investors just should be prepared for the fact that returns are much more likely to be muted over the next five years than what we’ve really benefited and enjoyed over the last five,” Jim McDonald, Northern Trust Bank chief investment strategist, said on Bloomberg Television. That view incorporates the prospect of lower valuations for Chinese firms facing more government involvement, he said.

Earlier in the session, Asian stocks were mixed amid the debt crisis at China Evergrande Group and a short-term cash injection by the central bank to help soothe nerves. Stocks in China and Hong Kong bounced back following four straight days of losses. The MSCI Asia Pacific Index climbed as much as 0.4%. Technology was the best-performing sector on the gauge, led by Tencent and Alibaba Group. Stocks also gained in Japan, with the Topix halting a two-day decline. Friday’s advance helped pare the Asian benchmark’s losses this week to 1.6%. The gauge is still on course to snap a three-week rally, largely due to China-related concerns. Investors remain worried about the regulatory crackdown after Beijing targeted Macau’s casinos this week, with sentiment also hurt by weak economic data and the debt crisis at China Evergrande Group. Focus is also turning to the Federal Reserve’s policy meeting next week, with traders hoping to get more clues about the timeline for paring bond purchases.

You now you have a number of serious risks in China, especially the one around systemic risk with Evergrande,” Frank Benzimra, head of Asia equity strategy at SocGen, said on Bloomberg TV. “We see more upside on the onshore than offshore part of the market. It’s a little bit early for bottom-fishing in the internet space.”

Japanese stocks traded higher in the afternoon session, overcoming early fluctuations, with electronics makers and telecommunications providers driving gains in the Topix. The Topix rose 0.5% to 2,100.17 at the 3 p.m. Tokyo close, while the Nikkei advanced 0.6% to 30,500.05. SoftBank Group contributed the most to the Topix’s gain, increasing 1.8%. Out of 2,184 shares in the index, 1,422 rose and 644 fell, while 118 were unchanged.  More than 4 trillion yen worth of shares traded hands on the first section of the Tokyo Stock Exchange, the most since May.  Running shoes and sportswear maker Asics dropped 3.2% after local broadcaster NHK reported the Tokyo Marathon will be canceled this year due to Tokyo still being under a state of emergency. Asics is one of the sponsors for the race

In rates, yields on the benchmark 10-year notes held around levels touched yesterday, after an unexpectedly strong retail sales reading. Treasuries were steady with the curve slightly steeper, pivoting around an unchanged 7-year sector. Treasury yields remain within a basis point of Thursday’s close, trading slightly richer across long-end of the curve, marginally flattening 2s10s, 5s30s spreads; the 10-year yield at 1.3429% was near top of Thursday’s range, outperforming bunds and gilts by 2.5bp and 1bp respectively and little changed on the week. Bunds underperform over early European session, with futures contract gaining momentum after breaching Thursday’s low. 

In FX, the Bloomberg Dollar Spot Index was little changed even as the greenback was weaker against most of its Group-of-10 peers; commodity currencies led advances after rebounding in the Asian session. The pound was steady against the dollar, but underperformed most of its Group-of-10 peers after U.K. retail sales fell unexpectedly for a fourth month in August, the worst stretch of declines in at least 25 years. Attention turns to the Bank of England’s rate decision next week. Australia’s dollar rose against all its Group-of-10 peers as an absence of further negative news helped restore some confidence in the global recovery. New Zealand’s dollar was sold after the nation extended the suspension of a travel bubble with Australia for eight weeks, a trader said.

In commodities, oil slipped, while gold advanced. An index of commodity prices dipped, but remains in sight of a record hit in 2011, underscoring the inflation concerns rippling across the world economy.

Looking at the day ahead now, the only thing on the US calendar is the University of Michigan’s preliminary consumer sentiment index for September. Otherwise, central bank speakers include the ECB’s Makhlouf.

Market Snapshot

  • S&P 500 futures little changed at 4,476.00
  • STOXX Europe 600 up 0.56% to 468.57
  • MXAP up 0.3% to 203.41
  • MXAPJ up 0.3% to 650.76
  • Nikkei up 0.6% to 30,500.05
  • Topix up 0.5% to 2,100.17
  • Hang Seng Index up 1.0% to 24,920.76
  • Shanghai Composite up 0.2% to 3,613.97
  • Sensex up 0.2% to 59,256.49
  • Australia S&P/ASX 200 down 0.8% to 7,403.72
  • Kospi up 0.3% to 3,140.51
  • Brent Futures down 0.66% to $75.17/bbl
  • Gold spot up 0.5% to $1,762.19
  • U.S. Dollar Index down 0.13% to 92.815
  • German 10Y yield rose 2bps to -0.281%
  • Euro little changed at $1.1782

Top Overnight News from Bloomberg

  • British consumers expect inflation will remain above the Bank of England’s target for at least the next five years, a survey showed, in an indication that attitudes about rising prices are becoming entrenched
  • The Federal Reserve will probably hint at its meeting next week that it is moving toward scaling back monthly asset purchases and make a formal announcement in November, according a Bloomberg survey of economists
  • China boosted its injection of short-term cash into the financial system in a sign the authorities are seeking to soothe market nerves frayed by concern over quarter-end funding needs and China Evergrande Group’s debt crisis
  • The European Central Bank dismissed a Financial Times report that chief economist Philip Lane told analysts privately the institution expects to reach its 2% inflation target by 2025
  • “Market interest rates have relaxed in cumulative terms since our monetary policy meeting in June,” ECB Governing Council member Pablo Hernandez de Cos says. “However, this relaxation has been reversed in recent weeks, serving as a reminder that financing conditions remain highly volatile in the context of uncertainty and highly dependent on monetary policy support”
  • U.K. retail sales fell unexpectedly for a fourth month in August, the longest stretch of declines in at least 25 years, raising concerns about the economic recovery as a resurgence of coronavirus cases and supply shortages take a toll

A more detailed look at global markets courtesy of Newsquawk

Asian equity markets traded mixed with the region tentative ahead of several APAC market closures next week, albeit with the mood at a slight improvement from the negative bias stateside, where strong data supported taper calls approaching quad witching hour. The ASX 200 (-0.8%) underperformed with the index pressured by hefty losses in the mining-related sectors after recent declines in underlying commodity prices due to a firmer greenback and Chinese efforts to contain prices through its state reserves. The mood in Australia was also dampened by fears of a backlash from China to the recent AUKUS security pact and with M&A discussions between private equity and Iress failing to reach an agreement which resulted in double-digit percentage losses for shares in the latter. The Nikkei 225 (+0.6%) was positive and tested the 30,500 level with the index getting an uplift from a mostly weaker JPY, but with gains capped by the ongoing COVID outbreak and with the Cabinet Office lowering its overall economic assessment for the first time in four months. The Hang Seng (+1.0%) and the Shanghai Comp. (+0.2%) lacked firm commitment ahead of a four-day weekend in the mainland due to the Mid-Autumn Festival and with some brief support after the PBoC’s liquidity efforts involving a total CNY 100bln injection evenly split between 7-day and 14-day reverse repos. In addition, plenty of focus remained on China Evergrande with its shares severely hit again on default fears and reports that suggested the unlikelihood of a government bailout, although there was some reprieve to affiliate Evergrande Property Services as its shares rose around 8% which seems inconsequential compared to its near-50% decline YTD. Finally, 10yr JGBs were subdued following the spillover selling from USTs and gains in Japanese stocks, with demand also hampered by the lack of BoJ purchases in the market today with the central bank instead offering to buy JPY 75bln in 3yr-5yr corporate bonds from next Friday.

Top Asian News

  • HKEX Proposes SPAC Listing Fundraising to Be at Least HK$1b
  • China Mogul Loses $27 Billion in World’s Biggest Wealth Drop
  • Australia to Trial Home Quarantine for Vaccinated Arrivals
  • China Property, Tech Firms Stage Rebound on Bargain Hunting

Bourses in Europe has conformed to a mixed picture (Euro Stoxx 50 -0.3%; Stoxx 600 -0.3%) after failing to hold into the +1% gains seen at the open for the bellwether index, whilst Euro futures now mostly lower on Quad Witching Day. The FTSE 100 Dec contract fell under 7,000 as the Sep contract expired. US equity futures meanwhile have seen somewhat of a contained divergence before adopting a downside bias, with the RTY narrowly lagging. Back to Europe, the FTSE 100 (-0.1%) is among the straddlers in the region as the Basic Resource sector is once again under pressure – with the biggest losers in the index currently Anglo American (-3.5), Rio Tinto (-2.2%) and BHP (-1.7%) – with the former seeing a downgrade at Morgan Stanley, whilst Glencore (+0.1%) bucks the trend amid an upgrade at the bank. Euro-bourses see broad-based gains. Delving deeper into sectors, Autos and Parts are also on the backfoot amid the ongoing chip shortage. On the flip side, Travel & Leisure leads the gains with reports stating the UK travel red list could be more than halved from its current 62 for the double-jabbed, according to The Times. Turkey is tipped to be among those removed from the list. The UK Transport Minister is today expected to announce the scrapping of the amber list, thus there will only be red and green lists. In terms of individual movers, Commerzbank (+3.3%) holds onto gains after Handelsblatt reported that Cerberus is reportedly considering increasing its stake in the Co. from the current 5% mark via taking on the German state's 15.6% interest in Commerzbank if the German state wishes to sell its holding.

Top European News

  • ECB Says FT Report on Inflation Target Outlook Not Accurate
  • U.K. Retail Sales Fall in Worst Stretch for Shops Since 1996
  • Europe’s Gas Resumes Gains on Concerns Over LNG Plants, Supply
  • How the Pandemic Left British Households $1.2 Trillion Richer

In FX, the Dollar has lost some of its retail sales vigour and Philly Fed fizz amidst signs of stabilisation in US Treasuries, both outright and from a yield curve perspective, while technical traders may also be a bit discouraged by the fact that the DXY did not quite have the legs to at least touch the psychological 93.000 mark when upside momentum was building yesterday. Hence, the index has drifted back down into a comparatively tight 92.639-760 range vs 92.965-467 extremes on Thursday and the Buck has unwound gains vs most major peers bar the Yen that is retreating closer to 110.00 again. Ahead, eyes on preliminary Michigan sentiment to see if the survey echoes upbeat regional vibes for September that kicked off with the Empire State, but also monitoring stocks over Quad Witching.

  • AUD/CAD/NZD - No surprise to see the Aussie strike while the Greenback is waning after its sharp decline on multiple factors this week (dovish RBA rate guidance, ongoing slump in iron ore, poor jobs data and heightened tensions with China), as Aud/Usd reclaims 0.7300+ status and the Aud/Nzd cross also regains some composure on the 1.0300 handle as the Kiwi lags below 0.7100 against its US counterpart in wake of a marked deterioration in NZ manufacturing PMI into contractionary territory. However, the Aussie may find further upside progress capped by decent option expiry interest at the 0.7325 strike (1 bn) or even get drawn back to similar size at the round number (1.1 bn to be precise), and the same goes for the Loonie given expiries between 1.2635-50 (1 bn) and at 1.2700 (1 bn), not to mention the loss of bullish impetus from WTI crude that is consolidating around Usd 72/brl. Nevertheless, Usd/Cad has retreated a bit further from w-t-d peaks to pivot 1.2650 between 1.2708-1.2600 parameters.
  • EUR/CHF/GBP - All marginally firmer vs the Dollar, but unconvincingly and still on course to end the week with net losses as the Euro meanders below 1.1800 and above 1.1750 where hefty option expiries reside (1.2 bn and 1.8 bn trailing down to 1.1745), the Franc straddles 0.9270 and Sterling rotates either side of 1.3800 following disappointing UK retail sales data and a pick-up in inflation expectations via the latest BoE/Kantar Attitudes Survey. Note also, Cable appears contained to an extent by technical levels in the form of the 50 and 21 DMAs that are situated at 1.3803 and 1.3780 respectively today, while Eur/Gbp is flirting with its 50 DMA at 0.8543 after rejecting or respecting 0.8500 on Thursday.
  • JPY - As noted at the outset, the Yen is underperforming having narrowly failed to breach 109.00 and Usd/Jpy now looks intent on testing resistance/offers at the big figure above pending any further repatriation for month, Q3 and Japanese half FY end or another change in chart and fundamental dynamics.
  • SCANDI/EM - The Nok does not look too fazed by the pull-back in Brent as it eyes a Norges Bank hike, but the Rub, Mxn and Zar are on a weaker footing, while the Try has fallen further in advance of September’s CBRT policy meeting as year end inflation projections rise again. Conversely, the Cnh and Cny are on an even keel into a long Chinese holiday weekend with 7 and 14 day liquidity provided by the PBoC.

In commodities, WTI and Brent front month futures have been trimming the gains seen since yesterday’s European close, with the former now threatening a breach of USD 72/bbl to the downside (vs high 72.72/bbl) and the latter just north of USD 75/bbl (vs high 72.78/bbl). News flow has been light, but prices saw crude prices saw leg lower heading into the European cash open, seemingly in tandem with NatGas prices as Europe reacted to Biden’s commentary suggesting that there is evidence that gas prices should be falling and his admin is investigating why that was not the case. Aside from that, crude price action has been dictated by the overall market mood and price action in stocks. Turning to metals, spot gold and silver consolidate following yesterdays deep declines which saw the yellow metal briefly dip under USD 1,750/oz. Base metals meanwhile nurse yesterday’s losses, with, but LME copper remains sub-USD 9,500/t. Base metals, name iron and copper, are on the watch for any retaliation by China on Australia following the AUKUS security pact.

US Event Calendar

  • 10am: Sept. U. of Mich. Sentiment, est. 72.0, prior 70.3; Current Conditions, prior 78.5; Expectations, prior 65.1
  • 10am: Sept. U. of Mich. 1 Yr Inflation, est. 4.7%, prior 4.6%; 5-10 Yr Inflation, prior 2.9%

DB's Jim Reid concludes the overfnight wrap

If someone looks at my browser history over the last 18 hours they will see a stream of entries along the lines of “will my golf be affected if I have to have knee replacement surgery”. I’ve been quite discouraged by some of the articles but have decided to focus on the YouTube clips of 80 year olds with fake knees hitting it as far as I do now. So after having microfracture surgery yesterday I was told the hole in my knee was far bigger than was thought and that I likely have arthritis in some form and will probably need a knee replacement relatively soon. So I’m looking for inspirational stories from my readers today, who may have been through this sort of thing, preferably telling me how I can not only get back on the golf course, but actually have the chance to still get better and better. Only positive answers or lies will be read.

There are a few aching joints in markets at the moment but for now it’s mild and still heavily medicated by prior fiscal and monetary medicine. There is certainly a whiff of stagflation fears in the air though but I would stress that real-time growth is still pretty high but it’s just that expectations are coming down from even higher levels earlier in the summer. Inflation forces have remained almost exclusively firmer over this period notwithstanding a slight miss on US CPI this week at what are still very elevated levels.

Talking of inflation, there was an interesting article in the FT last night saying that the ECB expects the region to reach its 2% inflation target by 2025, which would suggest that the central bank could raise interest rates as soon as 2023. This might get a little traction today but the market will likely think that there’s a lot of water that needs to flow under the bridge before we get to 2023, let alone 2025. However, if a path to such a number does appear in their forecasts soon it will impact ECB messaging going forward which will be important to markets. The Euro rose +0.13% following the article’s release, but still fell -0.42% on the day versus the dollar, which was its worst day in nearly a month. Overnight, the ECB has rejected the accuracy of the FT report as they released a statement saying “The FT story is not accurate”, and that ECB Chief Economist Philip Lane said that he “didn’t say in any conversation with analysts that the euro area will reach 2% inflation soon after the end of the ECB’s projection horizon”.

Confusing the growth picture a little was the stronger US retail sales yesterday which brought forward a little taper risk back into the equation ahead of the Fed meeting next week. This sparked a mini sell off in US yields and left treasuries not far off where they were before the CPI miss on Tuesday.

Running through those themes in more depth, US retail sales unexpectedly rose +0.7% in August (vs. -0.7% expected), whilst the measure excluding autos also jumped +1.8% (vs. unch expected), so a solid outperformance. That said, the release wasn’t quite as strong as the headline figures suggested, since the July retail sales reading was revised down to show a larger -1.8% contraction (vs. -1.1% previously), so a bit less solid than on first inspection. Nevertheless, Treasury yields spiked higher in response, seeing an intraday peak of 1.350%, before falling back to close at 1.338%. The overall move left them up +3.9bps on the previous day, as investors moved to accelerate the likely path of future rate hikes.

The prospect of less monetary stimulus weighed on US equities yesterday with the S&P 500 falling back -0.16% (but comfortably off the lows) after moving between gains and losses for much of the session. Retailing stocks (+0.69%) and consumer services (+0.23%) outperformed on the better-than-expected retail print, while tech stocks also outperformed slightly with the NASDAQ eking out a +0.13% gain. One sector that really outpaced the market was airline stocks, which gained +1.56% - partly on news that the UK will be easing travel restrictions on at least 30 countries currently on the UK’s “red list”. European equities topped their US peers, with the STOXX 600 up +0.44% as bourses across the continent moved higher, but much of that was a catch-up to the previous day’s rally in the US, which took place shortly after the European close.

Amidst the broader selloff, commodities also lost ground for the first time this week, with Bloomberg’s Commodity Spot Index (-1.00%) moving off its high for the decade thanks to a broad decline across the asset class. One decline in particular came from European natural gas prices, which fell by a massive -10.54% as they paused for breath following their blistering run higher. That said, even that decline still leaves them up +9.21% for the week so far, so we’re hardly out of the woods yet on that front. Otherwise, oil prices just about maintained their upward momentum as Brent Crude (+0.28%) saw a moderate daily move, whilst gold (-2.25%) fell to a 1-month low as it experienced its worst daily performance since early-August.

Asian markets are mostly trading higher this morning, with the Nikkei (+0.53%), Hang Seng (+0.47%) and Kospi (+0.15%) all advancing. Chinese bourses are a bit mixed though with the CSI (+0.27%) up, whereas the Shanghai Comp (-0.59%) and Shenzhen Comp (-0.65%) have lost ground, which comes in spite of the PBoC increasing its cash injections into the financial system as risks associated with the debt crisis at the Evergrande Group are dampening sentiment. The injection totalled CNY 90bn of funds, which is the most since February. Outside of Asia, yields on 10y USTs are broadly stable along with futures on the S&P 500 (+0.01%), but those on the Stoxx 50 are up +0.56%.

In Germany, there’s now just a week on Sunday remaining until the federal election, and a fresh round of polls continue to indicate a pretty consistent lead for the centre-left SPD, with Chancellor Merkel’s CDU/CSU bloc trailing behind, and the Greens then in 3rd place. One from YouGov yesterday gave them 25%, ahead of the CDU/CSU on 20% and the Greens on 15%. Then another from Kantar put the SPD on 26%, ahead of the CDU/CSU on 20% and the Greens on 17%. And finally, another came from Infratest dimap that put the SPD on 26%, the CDU/CSU on 22%, and the Greens on 15%. These polls have been remarkably consistent over the last couple of weeks.

Elsewhere in Europe, sovereign bond yields also spiked following the US retail sales release, but they then fell back with yields on 10yr bunds (+0.4bps), OATs (-0.0bps) and BTPs (-0.8bps) all near unchanged by the end of the session. The main exception were gilts, where the short end of the curve saw yields press higher still, with those on 2yr (+2.1bps) and 5yr (+3.7bps) gilts climbing to fresh post-pandemic highs as investors continued to bring forward the timing of potential BoE rate hikes. Meanwhile, 10yr gilt yields rose +3.9bps to 0.817%, their highest level since the start of June and just over +30bps higher than its early-August lows.

Turning to the pandemic, there were further signs of a return to normality after the World Economic Forum said that they planned to return to Davos in person for their annual meeting in January. I certainly missed the uniqueness of the event last year. Separately, the UK’s ONS reported that 93.6% of adults in England were estimated to have Covid antibodies in the week ending August 29, but this was actually down four-tenths on the previous week’s peak of 94.0%. Furthermore, among those in their 70s, the decline in antibodies over recent months is now statistically significant, with the 75-79 age bracket seeing levels fall from a peak of 96.6% in late-May to 90.2% in late-August. Indicators like these can be expected to lead to further calls for boosters for those who were vaccinated some months ago. In the US, boosters could be authorised as soon as next week by federal regulators, especially for those over the age of 65 and other at-risk individuals. The FDA is meeting today to discuss Pfizer’s application for a third shot of its vaccine, with the CDC holding a two-day meeting next week on booster shots in general.

Looking at yesterday’s other data, the weekly initial jobless claims for the week through September 11 rose to 332k (vs. 322k expected), but that didn’t stop the 4-week moving average falling to 335.75k, which is its lowest level since the pandemic began. The claims number will be impacted by recent auto production shutdowns due to the worldwide chip shortage. Otherwise, the Philadelphia Fed’s business outlook for September rose to 30.7 (vs. 19.0 expected).

To the day ahead now, and data highlights include UK retail sales for August, the final Euro Area CPI reading for August, and the University of Michigan’s preliminary consumer sentiment index for September. Otherwise, central bank speakers include the ECB’s Makhlouf.

Tyler Durden Fri, 09/17/2021 - 08:04

Read More

Continue Reading

International

Analyst reviews Apple stock price target amid challenges

Here’s what could happen to Apple shares next.

Published

on

They said it was bound to happen.

It was Jan. 11, 2024 when software giant Microsoft  (MSFT)  briefly passed Apple  (AAPL)  as the most valuable company in the world.

Microsoft's stock closed 0.5% higher, giving it a market valuation of $2.859 trillion. 

It rose as much as 2% during the session and the company was briefly worth $2.903 trillion. Apple closed 0.3% lower, giving the company a market capitalization of $2.886 trillion. 

"It was inevitable that Microsoft would overtake Apple since Microsoft is growing faster and has more to benefit from the generative AI revolution," D.A. Davidson analyst Gil Luria said at the time, according to Reuters.

The two tech titans have jostled for top spot over the years and Microsoft was ahead at last check, with a market cap of $3.085 trillion, compared with Apple's value of $2.684 trillion.

Analysts noted that Apple had been dealing with weakening demand, including for the iPhone, the company’s main source of revenue. 

Demand in China, a major market, has slumped as the country's economy makes a slow recovery from the pandemic and competition from Huawei.

Sales in China of Apple's iPhone fell by 24% in the first six weeks of 2024 compared with a year earlier, according to research firm Counterpoint, as the company contended with stiff competition from a resurgent Huawei "while getting squeezed in the middle on aggressive pricing from the likes of OPPO, vivo and Xiaomi," said senior Analyst Mengmeng Zhang.

“Although the iPhone 15 is a great device, it has no significant upgrades from the previous version, so consumers feel fine holding on to the older-generation iPhones for now," he said.

A man scrolling through Netflix on an Apple iPad Pro. Photo by Phil Barker/Future Publishing via Getty Images.

Future Publishing/Getty Images

Big plans for China

Counterpoint said that the first six weeks of 2023 saw abnormally high numbers with significant unit sales being deferred from December 2022 due to production issues.

Apple is planning to open its eighth store in Shanghai – and its 47th across China – on March 21.

Related: Tech News Now: OpenAI says Musk contract 'never existed', Xiaomi's EV, and more

The company also plans to expand its research centre in Shanghai to support all of its product lines and open a new lab in southern tech hub Shenzhen later this year, according to the South China Morning Post.

Meanwhile, over in Europe, Apple announced changes to comply with the European Union's Digital Markets Act (DMA), which went into effect last week, Reuters reported on March 12.

Beginning this spring, software developers operating in Europe will be able to distribute apps to EU customers directly from their own websites instead of through the App Store.

"To reflect the DMA’s changes, users in the EU can install apps from alternative app marketplaces in iOS 17.4 and later," Apple said on its website, referring to the software platform that runs iPhones and iPads. 

"Users will be able to download an alternative marketplace app from the marketplace developer’s website," the company said.

Apple has also said it will appeal a $2 billion EU antitrust fine for thwarting competition from Spotify  (SPOT)  and other music streaming rivals via restrictions on the App Store.

The company's shares have suffered amid all this upheaval, but some analysts still see good things in Apple's future.

Bank of America Securities confirmed its positive stance on Apple, maintaining a buy rating with a steady price target of $225, according to Investing.com

The firm's analysis highlighted Apple's pricing strategy evolution since the introduction of the first iPhone in 2007, with initial prices set at $499 for the 4GB model and $599 for the 8GB model.

BofA said that Apple has consistently launched new iPhone models, including the Pro/Pro Max versions, to target the premium market. 

Analyst says Apple selloff 'overdone'

Concurrently, prices for previous models are typically reduced by about $100 with each new release. 

This strategy, coupled with installment plans from Apple and carriers, has contributed to the iPhone's installed base reaching a record 1.2 billion in 2023, the firm said.

More Tech Stocks:

Apple has effectively shifted its sales mix toward higher-value units despite experiencing slower unit sales, BofA said.

This trend is expected to persist and could help mitigate potential unit sales weaknesses, particularly in China. 

BofA also noted Apple's dominance in the high-end market, maintaining a market share of over 90% in the $1,000 and above price band for the past three years.

The firm also cited the anticipation of a multi-year iPhone cycle propelled by next-generation AI technology, robust services growth, and the potential for margin expansion.

On Monday, Evercore ISI analysts said they believed that the sell-off in the iPhone maker’s shares may be “overdone.”

The firm said that investors' growing preference for AI-focused stocks like Nvidia  (NVDA)  has led to a reallocation of funds away from Apple. 

In addition, Evercore said concerns over weakening demand in China, where Apple may be losing market share in the smartphone segment, have affected investor sentiment.

And then ongoing regulatory issues continue to have an impact on investor confidence in the world's second-biggest company.

“We think the sell-off is rather overdone, while we suspect there is strong valuation support at current levels to down 10%, there are three distinct drivers that could unlock upside on the stock from here – a) Cap allocation, b) AI inferencing, and c) Risk-off/defensive shift," the firm said in a research note.

Related: Veteran fund manager picks favorite stocks for 2024

Read More

Continue Reading

International

Major typhoid fever surveillance study in sub-Saharan Africa indicates need for the introduction of typhoid conjugate vaccines in endemic countries

There is a high burden of typhoid fever in sub-Saharan African countries, according to a new study published today in The Lancet Global Health. This high…

Published

on

There is a high burden of typhoid fever in sub-Saharan African countries, according to a new study published today in The Lancet Global Health. This high burden combined with the threat of typhoid strains resistant to antibiotic treatment calls for stronger prevention strategies, including the use and implementation of typhoid conjugate vaccines (TCVs) in endemic settings along with improvements in access to safe water, sanitation, and hygiene.

Credit: IVI

There is a high burden of typhoid fever in sub-Saharan African countries, according to a new study published today in The Lancet Global Health. This high burden combined with the threat of typhoid strains resistant to antibiotic treatment calls for stronger prevention strategies, including the use and implementation of typhoid conjugate vaccines (TCVs) in endemic settings along with improvements in access to safe water, sanitation, and hygiene.

 

The findings from this 4-year study, the Severe Typhoid in Africa (SETA) program, offers new typhoid fever burden estimates from six countries: Burkina Faso, Democratic Republic of the Congo (DRC), Ethiopia, Ghana, Madagascar, and Nigeria, with four countries recording more than 100 cases for every 100,000 person-years of observation, which is considered a high burden. The highest incidence of typhoid was found in DRC with 315 cases per 100,000 people while children between 2-14 years of age were shown to be at highest risk across all 25 study sites.

 

There are an estimated 12.5 to 16.3 million cases of typhoid every year with 140,000 deaths. However, with generic symptoms such as fever, fatigue, and abdominal pain, and the need for blood culture sampling to make a definitive diagnosis, it is difficult for governments to capture the true burden of typhoid in their countries.

 

“Our goal through SETA was to address these gaps in typhoid disease burden data,” said lead author Dr. Florian Marks, Deputy Director General of the International Vaccine Institute (IVI). “Our estimates indicate that introduction of TCV in endemic settings would go to lengths in protecting communities, especially school-aged children, against this potentially deadly—but preventable—disease.”

 

In addition to disease incidence, this study also showed that the emergence of antimicrobial resistance (AMR) in Salmonella Typhi, the bacteria that causes typhoid fever, has led to more reliance beyond the traditional first line of antibiotic treatment. If left untreated, severe cases of the disease can lead to intestinal perforation and even death. This suggests that prevention through vaccination may play a critical role in not only protecting against typhoid fever but reducing the spread of drug-resistant strains of the bacteria.

 

There are two TCVs prequalified by the World Health Organization (WHO) and available through Gavi, the Vaccine Alliance. In February 2024, IVI and SK bioscience announced that a third TCV, SKYTyphoid™, also achieved WHO PQ, paving the way for public procurement and increasing the global supply.

 

Alongside the SETA disease burden study, IVI has been working with colleagues in three African countries to show the real-world impact of TCV vaccination. These studies include a cluster-randomized trial in Agogo, Ghana and two effectiveness studies following mass vaccination in Kisantu, DRC and Imerintsiatosika, Madagascar.

 

Dr. Birkneh Tilahun Tadesse, Associate Director General at IVI and Head of the Real-World Evidence Department, explains, “Through these vaccine effectiveness studies, we aim to show the full public health value of TCV in settings that are directly impacted by a high burden of typhoid fever.” He adds, “Our final objective of course is to eliminate typhoid or to at least reduce the burden to low incidence levels, and that’s what we are attempting in Fiji with an island-wide vaccination campaign.”

 

As more countries in typhoid endemic countries, namely in sub-Saharan Africa and South Asia, consider TCV in national immunization programs, these data will help inform evidence-based policy decisions around typhoid prevention and control.

 

###

 

About the International Vaccine Institute (IVI)
The International Vaccine Institute (IVI) is a non-profit international organization established in 1997 at the initiative of the United Nations Development Programme with a mission to discover, develop, and deliver safe, effective, and affordable vaccines for global health.

IVI’s current portfolio includes vaccines at all stages of pre-clinical and clinical development for infectious diseases that disproportionately affect low- and middle-income countries, such as cholera, typhoid, chikungunya, shigella, salmonella, schistosomiasis, hepatitis E, HPV, COVID-19, and more. IVI developed the world’s first low-cost oral cholera vaccine, pre-qualified by the World Health Organization (WHO) and developed a new-generation typhoid conjugate vaccine that is recently pre-qualified by WHO.

IVI is headquartered in Seoul, Republic of Korea with a Europe Regional Office in Sweden, a Country Office in Austria, and Collaborating Centers in Ghana, Ethiopia, and Madagascar. 39 countries and the WHO are members of IVI, and the governments of the Republic of Korea, Sweden, India, Finland, and Thailand provide state funding. For more information, please visit https://www.ivi.int.

 

CONTACT

Aerie Em, Global Communications & Advocacy Manager
+82 2 881 1386 | aerie.em@ivi.int


Read More

Continue Reading

International

US Spent More Than Double What It Collected In February, As 2024 Deficit Is Second Highest Ever… And Debt Explodes

US Spent More Than Double What It Collected In February, As 2024 Deficit Is Second Highest Ever… And Debt Explodes

Earlier today, CNBC’s…

Published

on

US Spent More Than Double What It Collected In February, As 2024 Deficit Is Second Highest Ever... And Debt Explodes

Earlier today, CNBC's Brian Sullivan took a horse dose of Red Pills when, about six months after our readers, he learned that the US is issuing $1 trillion in debt every 100 days, which prompted him to rage tweet, (or rageX, not sure what the proper term is here) the following:

We’ve added 60% to national debt since 2018. Germany - a country with major economic woes - added ‘just’ 32%.   

Maybe it will never matter.   Maybe MMT is real.   Maybe we just cancel or inflate it out. Maybe career real estate borrowers or career politicians aren’t the answer.

I have no idea.  Only time will tell.   But it’s going to be fascinating to watch it play out.

He is right: it will be fascinating, and the latest budget deficit data simply confirmed that the day of reckoning will come very soon, certainly sooner than the two years that One River's Eric Peters predicted this weekend for the coming "US debt sustainability crisis."

According to the US Treasury, in February, the US collected $271 billion in various tax receipts, and spent $567 billion, more than double what it collected.

The two charts below show the divergence in US tax receipts which have flatlined (on a trailing 6M basis) since the covid pandemic in 2020 (with occasional stimmy-driven surges)...

... and spending which is about 50% higher compared to where it was in 2020.

The end result is that in February, the budget deficit rose to $296.3 billion, up 12.9% from a year prior, and the second highest February deficit on record.

And the punchline: on a cumulative basis, the budget deficit in fiscal 2024 which began on October 1, 2023 is now $828 billion, the second largest cumulative deficit through February on record, surpassed only by the peak covid year of 2021.

But wait there's more: because in a world where the US is spending more than twice what it is collecting, the endgame is clear: debt collapse, and while it won't be tomorrow, or the week after, it is coming... and it's also why the US is now selling $1 trillion in debt every 100 days just to keep operating (and absorbing all those millions of illegal immigrants who will keep voting democrat to preserve the socialist system of the US, so beloved by the Soros clan).

And it gets even worse, because we are now in the ponzi finance stage of the Minsky cycle, with total interest on the debt annualizing well above $1 trillion, and rising every day

... having already surpassed total US defense spending and soon to surpass total health spending and, finally all social security spending, the largest spending category of all, which means that US debt will now rise exponentially higher until the inevitable moment when the US dollar loses its reserve status and it all comes crashing down.

We conclude with another observation by CNBC's Brian Sullivan, who quotes an email by a DC strategist...

.. which lays out the proposed Biden budget as follows:

The budget deficit will growth another $16 TRILLION over next 10 years. Thats *with* the proposed massive tax hikes.

Without them the deficit will grow $19 trillion.

That's why you will hear the "deficit is being reduced by $3 trillion" over the decade.

No family budget or business could exist with this kind of math.

Of course, in the long run, neither can the US... and since neither party will ever cut the spending which everyone by now is so addicted to, the best anyone can do is start planning for the endgame.

Tyler Durden Tue, 03/12/2024 - 18:40

Read More

Continue Reading

Trending